Fundraising Fox

Jonathan Naccache

Founder

Co-founder (Directeur de la publication) at Brink Therapeutics

Paris, Île-de-France, France

FoundedBrink Therapeutics

About

Jonathan Naccache is the co-founder and CEO of Brink Therapeutics, a company developing genome engineering tools for cell and gene therapy. He holds a Ph.D. from ESPCI (PSL) and is an alumnus of INSEAD.

Co-founder (Directeur de la publication) at Brink Therapeutics

Intro paths

→

In turn, Jonathan can intro founders to Brink Therapeutics's investors below.

Brink Therapeutics's investors · 3

BreegaLondon · $540K – $16.2M checksKima VenturesParis · $50K – $5M checksKurma PartnersParis · $162K – $10.8M checks

Experience

  1. Brink TherapeuticsCEO & Co-foundercurrent2024 — presentParis, Île-de-France, France
  2. DetectResearch And Development Scientist2019 — 2024Paris, Île-de-France, France
  3. Harvard UniversityResearch Fellow - Department of Systems Biology2019Greater Boston Area
  4. iGEM CompetitionMember of the team iGEM Pasteur Paris 2018 - Gold medalist2018Pasteur Institute, Paris, France
  5. SUEZJunior Research Engineer2017Montpellier Area, France
  6. INSERM UNIT UMR-S 1193Junior Research Scientist2016Hôpital Paul Brousse, Centre hépatobiliaire, Villejuif

Skills & more

RechercheBiologie moléculaireBiotechnologie3

Languages Anglais · Français

From Jonathan's professional profile.

Frequently asked questions

Who is Jonathan Naccache?
Jonathan Naccache is the co-founder and CEO of Brink Therapeutics, a company developing genome engineering tools for cell and gene therapy. He holds a Ph.D. from ESPCI (PSL) and is an alumnus of INSEAD.
Where does Jonathan Naccache work?
Jonathan Naccache is Co-founder (Directeur de la publication) of Brink Therapeutics.
What companies did Jonathan Naccache found?
Jonathan Naccache founded Brink Therapeutics.
Where did Jonathan Naccache go to school?
Jonathan Naccache studied at ESPCI Paris - PSL (Doctor of Philosophy - PhD, Biotechnology); INSEAD (Business Foundations Certificate, Business Administration and Management); SupBiotech, école de biotechnologies (Biotechnology engineer, Biotechnology).

Same school

Also attended ESPCI Paris - PSL5

Éric CarreelCo-founder & Chairman, Withings at 2050Viktor ZahoranskyCTO at A51Gabriel DumyCTO at Kolibriphilippe GILETFounder at AlediaMathieu CouadeCo-founder & CSO at Austral Dx

Also attended SupBiotech, école de biotechnologies2

Florian DenisPartner at ElaiaAishwarya ParthasarathyAssociate, Digital Medicine Strategy at Sofinnova Partners

Also attended Université Paris-Est Créteil19

Sylvain SachotPartner at Asabys PartnersHeli Mehtätalo-TakalaHead of Investor Relations & Communications at Innovestor VenturesHugo VautierBoard Member at SatganaCarlotta MarcheseRegulatory and Corporate Affairs Specialist at XGEN VentureCarlotta OrlandoInvestor at 360 CapitalZhang WengAI SW Engineer at Jolt Capital

+ 13 more

Also attended Boston University Metropolitan College2

Ole Henrik Bang-AndreasenInvestor at Avant BioDerek CallowOperating Partner at Seaside Ventures

Shared employers

Also worked at Brink Therapeutics1

Amine RajiCEO at Spore

Also worked at Detect1

Hugo BarraVenture Partner at Atlantico

Also worked at Harvard University361

Nathan BlecharczykCo-founder & CSO of AirbnbRyan SheaCo-founder of Blockstack (Stacks)Dave MunichielloInvestor at GV (Google Ventures)Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Logan HilleLife Sciences Analyst at CincyTechWalter KowtoniukInvestor at Third Rock Ventures

+ 355 more

Also worked at iGEM Competition9

Pim SwartAssociate Partner at Maven 11Fabian BäznerInvestor at Creator FundSteph AvraamidesUK Lead at Fifty YearsMax LebeauPrincipal at Positron VenturesFay HuoSenior Associate at Charlesbank Capital PartnersDavid LinFounder at Duffl

+ 3 more